Perhaps, because we did not see any decrease in symptoms of withdrawal syndrome following GLT‐1 activity, there are other adaptive mechanisms that, despite GLT‐1 activity, were able to maintain elevated glutamate levels in the hippocampal synaptic space due to morphine consumption. This evidence concerns the gene SLC1A2 and substance withdrawal syndrome.